BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Artivion Reports Second Quarter 2023 Financial Results

  Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the second quarter ended June 30, 2023.

  August 3, 2023

   · 

  18 min read
• Business

  10x Genomics Reports Second Quarter 2023 Financial Results

  10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June 30, 2023.

  August 3, 2023

   · 

  10 min read
• Business

  Trevi Therapeutics to Report Q2 2023 Financial Results and Provide a Corporate Update on August 10, 2023

  Trevi Therapeutics, Inc. (Nasdaq: TRVI) today announced that senior management will host a conference call and live audio webcast on Thursday, August 10, 2023, at 4:30 p.m. ET, to provide a corporate update and review the Company’s financial results for the second quarter ended June 30, 2023.

  August 3, 2023

   · 

  2 min read
• Business

  Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance

  Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, reported financial results for the quarter ended June 30, 2023.

  August 3, 2023

   · 

  16 min read
• Business

  Amylyx Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 10, 2023

  Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) will report its second quarter 2023 financial results on Thursday, August 10, 2023, following the close of the U.S. financial markets.

  August 3, 2023

   · 

  1 min read
• Business

  Natera Reports Second Quarter 2023 Financial Results

  Natera, Inc., a global leader in cell-free DNA testing, reported financial results for the second quarter ended June 30, 2023.

  August 3, 2023

   · 

  14 min read
• Biotech Beach

  Tandem Diabetes Care Announces Technology Access Program to Provide Customers with Purchase Pathway to the Tandem Mobi System

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced a limited time offer for its Tandem Choice technology access program.

  August 3, 2023

   · 

  9 min read
• Business

  Mirum Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

  Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for second quarter 2023 and provided a business update.

  August 3, 2023

   · 

  12 min read
• Business

  Deciphera Pharmaceuticals Announces Retirement of Daniel L. Flynn, Ph.D., and Appointment of Dashyant Dhanak, Ph.D., as Executive Vice President and Chief Scientific Officer

  Deciphera Pharmaceuticals, Inc. announced that the Company’s Founder, Executive Vice President, and Chief Scientific Officer, Daniel L. Flynn, Ph.D., will retire effective September 5, 2023 and will transition to a role as Senior Advisor to the Company.

  August 3, 2023

   · 

  7 min read
• Business

  Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results

  Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report second quarter 2023 financial results after the U.S. financial markets close on Thursday, August 10, 2023.

  August 3, 2023

   · 

  2 min read